Byron Donalds sold REGN on April 10, 2025 | PolitAlpha
Byron Donalds sold REGN (Regeneron Pharmaceuticals Inc) on Apr 10, 2025 with an estimated value between $1,000 and $15,000. This trade was filed under undisclosed. The stock is currently up 27.8% from the trade price.